What smart money is saying about Hays
HAS.L
No fund has written a full thesis on Hays in our archive, but 3 fund letters report a position in it — most recently Liontrust Global Recovery Fund in September 2026.
Get an email when a fund buys, sells or pitches it
3
Reported positions
0
Bought
0
Sold
4
Letters
Position history
Every position in Hays on record in the archive was reported in Q3 2026, across 3 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 0 | 0 |
Fund activity · 3 positions
- September 2026
“strong stock-specific returns from Moderna, Meta and Hays, all of which exceeded expectations.”
Hays - September 2026
“Top contributor Hays was a contributor during the quarter.”
Hays - September 2026
“The Fund’s key investment factors, namely Value, Recovery and Multi-Cap, were broadly supportive over the period, with performance benefiting in particular from the strength of the wider market. Key contributors included the outperformance of our smaller company holdings, underweights in AstraZeneca and British American Tobacco, and strong stock-specific returns from Hays, Everplay and Somero, all of which exceeded expectations.”
Hays
Also mentioned · 1
These funds discuss Hays — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedJupiter AMSeptember 2025
“Recruiters like Hays (for now no longer a position in the Fund) and Page Group (not owned) fell 21% and 14%, respectively,”
Hays
Read the letters behind these Hays positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger